Problems › Should We Buy a Competitor? › Law Firms
Acquisitions fail on integration far more often than on price, and the integration cost in lost utilisation and extended lock-up days is the figure least likely to have been modelled. The version of this question that applies to law firms is not the generic one. 19 of 28 equity partners aged 55 or over with no formal lateral hire programme or associate-to-partner track for eight years — so an answer that ignores 82 % realisation will be confidently wrong. The analysis has to start from 68 % utilisation and £184 k profit per equity partner rather than from revenue.
Acquisitions fail on integration far more often than on price, and the integration cost in lost utilisation and extended lock-up days is the figure least likely to have been modelled. The version of this question that applies to law firms is not the generic one. 19 of 28 equity partners aged 55 or over with no formal lateral hire programme or associate-to-partner track for eight years — so an answer that ignores 82 % realisation will be confidently wrong. The analysis has to start from 68 % utilisation and £184 k profit per equity partner rather than from revenue.
The case for buying a competitor is usually built on revenue synergies from combining the five practice groups, which are the least reliable category of benefit and the slowest to arrive. Cost synergies in support functions are more predictable, and the honest ones are usually smaller than the model assumes given current realisation and utilisation.
The number that decides most outcomes is integration cost — fee earner alignment, equity partner roles, client disruption, and the management attention diverted from the existing business for a year or more. It is routinely omitted because it is hard to estimate and does not appear on either firm's accounts.
The disciplined version asks what specifically you get that you could not build or buy more cheaply another way, and what the business looks like if none of the revenue synergies materialise.
These three together are the signature. One on its own usually points somewhere else.
✓ Equity partners frame the rationale around cross-selling between the five practice groups without quantifying the impact on utilisation or realisation.
✓ Integration steps are listed in partner meetings but no adjustment is made to lock-up days or profit per equity partner.
✓ The acquisition is discussed alongside the absence of a lateral hire programme and the stalled associate-to-partner track.
The move that usually makes it worse. Underwriting the deal on revenue synergies, which typically arrive late, smaller than modelled, or not at all.
It is for you if you run or finance a law firm and the rationale leans on cross-selling to each other's customers. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a law firm. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Ashgrove Legal LLP, a sample company profile used for testing rather than a customer — £24.8 m gross revenue from five practice groups.
Excerpt from a real Percision run · Pricing Strategy · sample company profile
The move. Scale the only practice hitting 88 % realisation to fund its own growth and close the succession gap.
| Investment required | £240 k (remaining FY2026 discretionary cap after £180 k IT commitment) |
| Expected return | 1.4–1.6× cash-on-cash within 24 months at current realisation rates. |
| Revenue, year 1 | £25.4–25.7 m firm-wide (+£0.6–0.9 m incremental) |
| Revenue, year 2 | £26.5–27.1 m firm-wide (+£1.1–1.3 m incremental from B&F segment) |
| Revenue, year 3 | £27.8–28.6 m firm-wide (+£1.3–1.5 m incremental) |
| Exit criteria | Strategy must be reversed if, within 18 months, segment revenue has not reached £2.4 m annualised OR cumulative net profit contribution is below £150 k, OR if any lateral hire’s personal billings fall below 1 200 hours in any rolling 6-month period. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For law firms it works through 82 % realisation, 68 % utilisation, £184 k profit per equity partner and 112 lock-up days, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Twice — once standalone, and once for what it is worth specifically to you. The gap between those is the most you can pay and still create value, and it is usually narrower than expected.
Cost, substantially. They are within your control and can be scheduled. Revenue synergies depend on customers behaving as modelled, which is the assumption most often wrong.
Integration consuming more management attention than anyone budgeted, so that both businesses underperform during the period the deal was supposed to be paying back.
Materially, yes. 19 of 28 equity partners aged 55 or over with no formal lateral hire programme or associate-to-partner track for eight years — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82 % realisation, 68 % utilisation, £184 k profit per equity partner, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82 % realisation and 68 % utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית